Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
Tilray shares are flat Thursday morning as the company prepares to report its fiscal second-quarter 2026 results after the bell, stirring investor interest.
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, is redefining what it means to drink mindfully with a collection that blends craft, creativity, and functionality. From hemp-derived delta-9 THC cocktails to zero-proof spirits and non-alcoholic beers, Tilray is making moderation feel indulgent, not limiting.
TORONTO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, invites Canadians to embrace mindful sipping this Dry January with cannabis‑infused beverages from Mollo and XMG. Under the banner “No Drinks doesn’t mean no drinks,” the campaign champions flavour‑forward options and consistent cannabinoid profiles, perfect for social hangs, solo downtime, and everything in between.
Cannabis has been removed from the federal government’s most restrictive drug category following a recent executive order by President Donald Trump. The move shifts marijuana from Schedule I, a group reserved for substances deemed to have no accepted medical use, to Schedule III.
Cannabis has been removed from the federal government’s most restrictive drug category following a recent executive order by President Donald Trump. The move shifts marijuana from Schedule I, a group reserved for substances deemed to have no accepted medical use, to Schedule III.
Date: 12/15/2025 1. Introduction Tilray Brands, Inc. (NASDAQ: TLRY) is a diversified global lifestyle consumer packaged goods (CPG) company operating at the dynamic intersection of the cannabis, alcoholic beverage, and wellness industries. Headquartered in New York City, Tilray boasts a significant operational footprint across Canada, the United States, Europe, Australia, New Zealand, and Latin America, [...]
